KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Change in Cash: 2009-2024

Historic Change in Cash for Rigel Pharmaceuticals (RIGL) over the last 16 years, with Dec 2024 value amounting to $24.0 million.

  • Rigel Pharmaceuticals' Change in Cash fell 131.16% to -$4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.1 million, marking a year-over-year decrease of 149.39%. This contributed to the annual value of $24.0 million for FY2024, which is 187.74% up from last year.
  • Per Rigel Pharmaceuticals' latest filing, its Change in Cash stood at $24.0 million for FY2024, which was up 187.74% from $8.3 million recorded in FY2023.
  • In the past 5 years, Rigel Pharmaceuticals' Change in Cash registered a high of $24.0 million during FY2024, and its lowest value of -$11.5 million during FY2021.
  • For the 3-year period, Rigel Pharmaceuticals' Change in Cash averaged around $12.6 million, with its median value being $8.3 million (2023).
  • As far as peak fluctuations go, Rigel Pharmaceuticals' Change in Cash tumbled by 246.24% in 2021, and later skyrocketed by 187.74% in 2024.
  • Over the past 5 years, Rigel Pharmaceuticals' Change in Cash (Yearly) stood at $7.9 million in 2020, then tumbled by 246.24% to -$11.5 million in 2021, then surged by 148.50% to $5.6 million in 2022, then soared by 49.52% to $8.3 million in 2023, then surged by 187.74% to $24.0 million in 2024.